Literature DB >> 687499

Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.

M Velasco, E Romero, H Bertoncini, A Urbina-Quintana, J Guevara, O Hernández-Pieretti.   

Abstract

1 The effect of propranolol was examined on a) blood pressure and heart rate responses due to i.v. hydrallazine b) modification of these cardiovascular parameters during cold pressor test c) urinary catecholamine excretion rate. 2 Intravenous hydrallazine reduced significantly mean blood pressure by 15.2 mm Hg and increased heart rate by 24.9 beats/min. Propranolol reduced significantly mean blood pressure by 19.0 mm Hg and heart rate by 14.1 beats/min. Hydrallazine plus propranolol caused a significant reduction of mean blood pressure (by 37.7 mm Hg) but this was not accompanied by a significant fall in heart rate (by 3.3 beats/min). 3 During the control period, cold pressor test increased mean blood pressure by 16.0 mm Hg. Heart rate was increased by 12.5 beats/min in four patients. However, there was a reduction in heart rate (5.5 beats/min) in two other patients. During the propranolol period, cold pressor test-induced increase of mean blood pressure was not reduced but propranolol blocked the increase of heart rate. 4 Urinary catecholamine excretion rate was increased during hydrallazine administration. This excretion was not modified by propranolol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687499      PMCID: PMC1429453          DOI: 10.1111/j.1365-2125.1978.tb04587.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  A study of the mechanism of the hemodynamic effects of hydralazine in man.

Authors:  B ABLAD
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

3.  Modification of pressor responses induced by 'cold' [proceedings].

Authors:  J G Maconochie; D A Richards; E P Woodings
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

4.  Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.

Authors:  M Velasco; K O'Malley; N W Robie; J Wells; Z H Israili; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

5.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

6.  Observation on the mechanism of renin release by hydralazine in hypertensive patients.

Authors:  H Ueda; Y Kaneko; T Takeda; T Ikeda; S Yagi
Journal:  Circ Res       Date:  1970-10       Impact factor: 17.367

7.  Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.

Authors:  M Velasco; C A Gilbert; C O Rutledge; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1975-08       Impact factor: 6.875

8.  Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.

Authors:  K O'Malley; M Velasco; J Wells; J L McNay
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

9.  Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.

Authors:  K O'Malley; M Velasco; J Wells; J McNay
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

  9 in total
  2 in total

1.  Effects of cold exposure on blood pressure, heart rate and forearm blood flow in normotensives during selective and non-selective beta-adrenoceptor blockade.

Authors:  H Houben; T Thien; G Wijnands; A Van't Laar
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

2.  Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.